,outcome,arm 1,arm 2
0,intervention,"amantadine, amantadine-treated group",
0,absolute changes in clinician-rated ABC-CVs for hyperactivity,-6.4,placebo
0,"absolute changes in clinician-rated ABC-CVs for hyperactivity, total study group","-1.9 versus 0.4, -2.1","-1.9 versus 0.4, -2.1"
